12 Month Price Forecast For CNMD
Distance to CNMD Price Forecasts
CNMD Price Momentum
🤔 Considering CONMED (CNMD)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: January 23, 2025 4:46 AM UTC
CNMD Analyst Ratings & Price Targets
Based on our analysis of 10 Wall Street analysts, CNMD has a consensus that is bullish. The median price target is $80.00, with forecasts ranging from $72.00 to $97.00. Currently, there are 4 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
With CNMD currently trading at $71.00, the median price forecast suggests a 12.7% upside. The most optimistic forecast comes from Mike Matson at Needham, projecting a 36.6% upside, while at provides the most conservative target, suggesting a 1.4% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CNMD Analyst Consensus
CNMD Price Target Range
Latest CNMD Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CNMD.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Oct 31, 2024 | Needham | Mike Matson | Buy | Reiterates | $97.00 |
| Oct 4, 2024 | Needham | Mike Matson | Buy | Reiterates | $97.00 |
| Aug 1, 2024 | Wells Fargo | Vik Chopra | Equal-Weight | Maintains | $71.00 |
| Aug 1, 2024 | Needham | Mike Matson | Buy | Maintains | $97.00 |
| Aug 1, 2024 | Piper Sandler | Matt O'Brien | Overweight | Maintains | $80.00 |
| Aug 1, 2024 | Stifel | Rick Wise | Buy | Maintains | $76.00 |
| Jul 25, 2024 | Needham | Mike Matson | Buy | Maintains | $106.00 |
| May 6, 2024 | Needham | Mike Matson | Buy | Reiterates | $107.00 |
| Apr 25, 2024 | Needham | Mike Matson | Buy | Maintains | $107.00 |
| Apr 25, 2024 | Wells Fargo | Vik Chopra | Equal-Weight | Maintains | $77.00 |
| Apr 25, 2024 | Piper Sandler | Matt O'Brien | Overweight | Maintains | $95.00 |
| Apr 25, 2024 | JP Morgan | Robbie Marcus | Overweight | Maintains | $75.00 |
| Feb 1, 2024 | JP Morgan | Robbie Marcus | Overweight | Maintains | $115.00 |
| Feb 1, 2024 | Piper Sandler | Matt O'Brien | Overweight | Maintains | $100.00 |
| Feb 1, 2024 | Needham | Mike Matson | Buy | Maintains | $129.00 |
| Feb 1, 2024 | Wells Fargo | Durgesh Chopra | Equal-Weight | Maintains | $98.00 |
| Oct 27, 2023 | Piper Sandler | Matt O'Brien | Overweight | Maintains | $130.00 |
| Oct 26, 2023 | Wells Fargo | Durgesh Chopra | Equal-Weight | Maintains | $107.00 |
| Oct 26, 2023 | Needham | Mike Matson | Buy | Maintains | $119.00 |
| Oct 26, 2023 | Stifel | Rick Wise | Buy | Maintains | $120.00 |
Stocks Similar to CONMED Corp
The following stocks are similar to CONMED based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
CONMED Corp (CNMD) Financial Data
CONMED Corp has a market capitalization of $2.19B with a P/E ratio of 16.8x. The company generates $1.29B in trailing twelve-month revenue with a 10.2% profit margin.
Revenue growth is +4.0% quarter-over-quarter, while maintaining an operating margin of +12.2% and return on equity of +15.2%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
CONMED Corp (CNMD) Company Overview
About CONMED Corp
Develops and sells surgical devices globally.
The company generates revenue by developing, manufacturing, and selling a wide range of surgical devices and related equipment for various medical procedures. CONMED's products cater to orthopedic, general surgery, and endoscopic technologies, targeting hospitals, surgery centers, and healthcare institutions. It markets its offerings under multiple brands, allowing for a diversified product range and customer base.
Founded in 1970 and headquartered in Largo, Florida, CONMED Corporation has established a strong presence in the medical technology sector. The company focuses on innovation and clinical solutions, providing products that support minimally invasive surgical techniques and enhance patient outcomes.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
4,000
CEO
Mr. Curt R. Hartman
Country
United States
IPO Year
1990
Website
www.conmed.comCONMED Corp (CNMD) Latest News & Analysis
Should Value Investors Buy CONMED (CNMD) Stock?
14 days agoZacks emphasizes its Rank system based on earnings estimates and revisions to identify strong stocks, while also monitoring value, growth, and momentum trends.
The Zacks Rank system highlights stocks with favorable earnings estimates, signaling potential investment opportunities amid value, growth, and momentum trends, influencing market performance.
CONMED Corporation to Announce Fourth Quarter 2024 Financial Results on February 5, 2025
16 days agoCONMED Corporation (NYSE: CNMD) will report Q4 2024 financial results on February 5, 2025, after market close. A conference call will follow at 4:30 p.m. ET for discussion.
The scheduled financial results and conference call indicate upcoming insights into CONMED's performance, impacting stock valuations and investor sentiment.
CONMED Corporation (NYSE: CNMD) executives will present at the J.P. Morgan Healthcare Conference on January 13, 2025. A live audio webcast will be available on their website.
CONMED's presentation at a major healthcare conference can influence investor sentiment and stock performance by highlighting strategic initiatives and financial health.
Investors are comparing Conmed (CNMD) and Align Technology (ALGN) for potential value opportunities in the Medical - Dental Supplies sector.
The comparison between Conmed and Align Technology highlights potential investment opportunities within the Medical-Dental Supplies sector, signaling value assessment for portfolio decisions.
CNMD is expected to grow due to strong products and recurring revenues, but it may encounter regulatory challenges, supply-chain issues, and cybersecurity risks.
CNMD's growth potential is tempered by regulatory, supply-chain, and cybersecurity risks, impacting its stability and future profitability, which are crucial for investment decisions.
CONMED Corporation (NYSE: CNMD) declared a quarterly cash dividend of $0.20 per share, payable on January 3, 2025, to shareholders of record as of December 20, 2024.
CONMED's quarterly dividend declaration signals financial stability and commitment to returning value to shareholders, potentially attracting income-focused investors.
Frequently Asked Questions About CNMD Stock
What is CONMED Corp's (CNMD) stock forecast for 2025?
Based on our analysis of 10 Wall Street analysts, CONMED Corp (CNMD) has a median price target of $80.00. The highest price target is $97.00 and the lowest is $72.00.
Is CNMD stock a good investment in 2025?
According to current analyst ratings, CNMD has 4 Buy ratings, 3 Hold ratings, and 0 Sell ratings. The stock is currently trading at $71.00. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for CNMD stock?
Wall Street analysts predict CNMD stock could reach $80.00 in the next 12 months. This represents a 12.7% increase from the current price of $71.00. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is CONMED Corp's business model?
The company generates revenue by developing, manufacturing, and selling a wide range of surgical devices and related equipment for various medical procedures. CONMED's products cater to orthopedic, general surgery, and endoscopic technologies, targeting hospitals, surgery centers, and healthcare institutions. It markets its offerings under multiple brands, allowing for a diversified product range and customer base.
What is the highest forecasted price for CNMD CONMED Corp?
The highest price target for CNMD is $97.00 from Mike Matson at Needham, which represents a 36.6% increase from the current price of $71.00.
What is the lowest forecasted price for CNMD CONMED Corp?
The lowest price target for CNMD is $72.00 from at , which represents a 1.4% increase from the current price of $71.00.
What is the overall CNMD consensus from analysts for CONMED Corp?
The overall analyst consensus for CNMD is bullish. Out of 10 Wall Street analysts, 4 rate it as Buy, 3 as Hold, and 0 as Sell, with a median price target of $80.00.
How accurate are CNMD stock price projections?
Stock price projections, including those for CONMED Corp, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
